C4 Therapeutics Inc. (CCCC)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1. 6,978,942 $25,124,191 +6% 1.57%
2. 6,852,744 $24,669,878 -1% 9.24%
3.
RA Capital Management

Peter Kolchinsky

4,878,000 $17,560,800 0.23%
4.
OrbiMed Advisors

Samuel Isaly

4,377,900 $15,760,440 0.32%
5.
Samlyn Capital

Robert Pohly

3,019,458 $10,870,050 0.16%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$5.60 5,667 Director 5,667 2023-02-08 Filing
$8.40 10,000 Officer, Director 10,000 2022-04-12 Filing
$19.00 5,263 Officer 5,263 2020-10-06 Filing
$19.00 5,030 Large Shareholder, Director 5,030 2020-10-06 Filing
$19.00 1,315 Director 15,994 2020-10-06 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$3.15 669 Officer 107,805 2025-02-18 Filing
$3.15 490 Officer 110,842 2025-02-14 Filing
$32.66 1,054 Officer 15,000 2022-01-04 Filing
$31.59 13,946 Officer 16,054 2022-01-04 Filing
$30.25 755 Director 10,952 2021-12-17 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 218,411 $349,458 0.02%
2. 89,633 $143,407 0%
3. 2,375 $4,156 0%
4. 425,096 $680 0%
5. 70 $112 0%
News See All